Literature DB >> 25087915

Blockage of melanocortin-4 receptors by intranasal HS014 attenuates single prolonged stress-triggered changes in several brain regions.

Lidia I Serova1, Marcela Laukova, Lishay G Alaluf, Esther L Sabban.   

Abstract

Melanocortin receptor four (MC4R) is implicated in regulation of stress-related functions. We previously demonstrated that intranasal infusion of MC4R antagonist HS014, shortly before single prolonged stress (SPS) animal model of post-traumatic stress disorder, lessened the development of anxiety- and depression-like behavior depending on the dose. Here, we evaluated effects of HS014 on SPS-elicited changes in hypothalamic-pituitary-adrenal axis and expression of several genes of interest in mediobasal hypothalamus, hippocampus, and locus coeruleus. Rats were given intranasal infusion of HS014 (3.5 ng or 100 μg) and 30 min later subjected to SPS stressors. Short-term responses of HS014 rats in comparison with vehicle-treated, evident 30 min following SPS stressors, included smaller rise in plasma corticosterone (100 μg HS014), absence of induction of corticotrophin-releasing hormone mRNA in mediobasal hypothalamus and of mRNA for tyrosine hydroxylase and dopamine-β hydroxylase in locus coeruleus. Long-term responses found 7 days after SPS stressors, included lower induction corticotrophin-releasing hormone mRNA levels in the mediobasal hypothalamus without effect on mRNAs for the glucocorticoid receptor (GR) and FK506-binding protein 51 (FKBP5), a component of GR co-chaperone complex; and no induction of GR protein in ventral hippocampus. Thus, antagonism of MC4R prior to SPS attenuates development of several abnormalities in gene expression in regions implicated in post-traumatic stress disorder. Blockade of brain melanocortine receptor 4 (MC4R) with intranasal infusion of the MC4R antagonist HS014 to rats prior to single prolonged stress (SPS) leads to faster termination of stress responses (30 min later) and prevents or attenuates SPS-triggered abnormal gene expression related to post-traumatic stress disorder (7 days later). Targeting of brain MC4R is a promising strategy to protect HPA axis, LC-NE (locus coeruleus-norepinephrine) systems and hippocampus from overstimulation.
© 2014 International Society for Neurochemistry.

Entities:  

Keywords:  corticotrophin-releasing hormone; dopamine β-hydroxylase; glucocorticoid receptor; intranasal infusion; locus coeruleus; tyrosine hydroxylase

Mesh:

Substances:

Year:  2014        PMID: 25087915     DOI: 10.1111/jnc.12847

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  10 in total

1.  Gastrodin reversed the traumatic stress-induced depressed-like symptoms in rats.

Authors:  Bombi Lee; Bongjun Sur; Mijung Yeom; Insop Shim; Hyejung Lee; Dae-Hyun Hahm
Journal:  J Nat Med       Date:  2016-07-14       Impact factor: 2.343

2.  Transgenerational Social Stress, Immune Factors, Hormones, and Social Behavior.

Authors:  Christopher A Murgatroyd; Jessica A Babb; Steven Bradburn; Lindsay M Carini; Gillian L Beamer; Benjamin C Nephew
Journal:  Front Ecol Evol       Date:  2016-01-12

3.  D-TRP(8)-γMSH Prevents the Effects of Endotoxin in Rat Skeletal Muscle Cells through TNFα/NF-KB Signalling Pathway.

Authors:  Ana Belén Gómez-SanMiguel; María Ángeles Villanúa; Ana Isabel Martín; Asunción López-Calderón
Journal:  PLoS One       Date:  2016-05-13       Impact factor: 3.240

4.  Adolescent Alcohol Exposure-Induced Changes in Alpha-Melanocyte Stimulating Hormone and Neuropeptide Y Pathways via Histone Acetylation in the Brain During Adulthood.

Authors:  Dadasaheb M Kokare; Evan J Kyzar; Huaibo Zhang; Amul J Sakharkar; Subhash C Pandey
Journal:  Int J Neuropsychopharmacol       Date:  2017-09-01       Impact factor: 5.176

5.  NPY1 Receptor Agonist Modulates Development of Depressive-Like Behavior and Gene Expression in Hypothalamus in SPS Rodent PTSD Model.

Authors:  Lidia Serova; Hannah Mulhall; Esther Sabban
Journal:  Front Neurosci       Date:  2017-04-19       Impact factor: 4.677

6.  Melanotan-II reverses autistic features in a maternal immune activation mouse model of autism.

Authors:  Elena Minakova; Jordan Lang; Jesus-Servando Medel-Matus; Georgianna G Gould; Ashley Reynolds; Don Shin; Andrey Mazarati; Raman Sankar
Journal:  PLoS One       Date:  2019-01-10       Impact factor: 3.240

Review 7.  Neuropeptides at the crossroad of fear and hunger: a special focus on neuropeptide Y.

Authors:  Lucas B Comeras; Herbert Herzog; Ramon O Tasan
Journal:  Ann N Y Acad Sci       Date:  2019-07-04       Impact factor: 5.691

8.  Comorbidity between Alzheimer's disease and major depression: a behavioural and transcriptomic characterization study in mice.

Authors:  Ana Martín-Sánchez; Janet Piñero; Lara Nonell; Magdalena Arnal; Elena M Ribe; Alejo Nevado-Holgado; Simon Lovestone; Ferran Sanz; Laura I Furlong; Olga Valverde
Journal:  Alzheimers Res Ther       Date:  2021-04-02       Impact factor: 6.982

9.  Interactions with the MC4R rs17782313 variant, mental stress and energy intake and the risk of obesity in Genome Epidemiology Study.

Authors:  Sunmin Park; James W Daily; Xin Zhang; Hyun Seok Jin; Hye Ja Lee; Yong Hyun Lee
Journal:  Nutr Metab (Lond)       Date:  2016-05-21       Impact factor: 4.169

10.  Evaluating the Levels of Nesfatin-1 and Ghrelin Hormones in Patients with Moderate and Severe Major Depressive Disorders.

Authors:  Sermin Algul; Oguz Ozcelik
Journal:  Psychiatry Investig       Date:  2017-12-01       Impact factor: 2.505

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.